Functional annotation of the Hippo pathway somatic mutations in human cancers

The Hippo pathway is commonly altered in cancer initiation and progression; however, exactly how this pathway becomes dysregulated to promote human cancer development remains unclear. Here we analyze the Hippo somatic mutations in the human cancer genome and functionally annotate their roles in targeting the Hippo pathway. We identify a total of 85 loss-of-function (LOF) missense mutations for Hippo pathway genes and elucidate their underlying mechanisms. Interestingly, we reveal zinc-finger domain as an integral structure for MOB1 function, whose LOF mutations in head and neck cancer promote tumor growth. Moreover, the schwannoma/meningioma-derived NF2 LOF mutations not only inhibit its tumor suppressive function in the Hippo pathway, but also gain an oncogenic role for NF2 by activating the VANGL-JNK pathway. Collectively, our study not only offers a rich somatic mutation resource for investigating the Hippo pathway in human cancers, but also provides a molecular basis for Hippo-based cancer therapy.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-11-21
DOI
https://doi.org/10.1038/s41467-024-54480-y
Citations
9
Primary Topic
Hippo pathway signaling and YAP/TAZ
Type
article
Field-Weighted Citation Impact
2.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Functional annotation of the Hippo pathway somatic mutations in human cancers

Bing Yang, Dmitry A. Fishman, Jiong Yan, Ruxi Qi et al.
9 citations
Nature Communications
Hippo pathway signaling and YAP/TAZ
2.93
article

Functional annotation of the Hippo pathway somatic mutations in human cancers

Bing Yang, Dmitry A. Fishman, Jiong Yan, Ruxi Qi, Kun‐Liang Guan, Zhen Huang, Congsheng Xu, Ray Luo, Di Xiao, Gayoung Seo, Jeongmin An, Zhipeng Meng, Colette Ahn, Han Han, Yuhan Liu, Wenqi Wang, Yue Xu, Shanshan Ren, Jiachen Yan, Tian Lan
article en
9 citations

Abstract

The Hippo pathway is commonly altered in cancer initiation and progression; however, exactly how this pathway becomes dysregulated to promote human cancer development remains unclear. Here we analyze the Hippo somatic mutations in the human cancer genome and functionally annotate their roles in targeting the Hippo pathway. We identify a total of 85 loss-of-function (LOF) missense mutations for Hippo pathway genes and elucidate their underlying mechanisms. Interestingly, we reveal zinc-finger domain as an integral structure for MOB1 function, whose LOF mutations in head and neck cancer promote tumor growth. Moreover, the schwannoma/meningioma-derived NF2 LOF mutations not only inhibit its tumor suppressive function in the Hippo pathway, but also gain an oncogenic role for NF2 by activating the VANGL-JNK pathway. Collectively, our study not only offers a rich somatic mutation resource for investigating the Hippo pathway in human cancers, but also provides a molecular basis for Hippo-based cancer therapy.

Nature CommunicationsVol. 15(1)
University of Miami (US), University of California, Irvine (US), Southern University of Science and Technology (CN), Westlake University (CN), Wuhan University (CN), Irvine University (US), Sylvester Comprehensive Cancer Center (US)
American Cancer Society, National Natural Science Foundation of China, National Institutes of Health, Young Scientists Fund, National Cancer Institute, National Institute of General Medical Sciences, Chao Family Comprehensive Cancer Center
Openalex Percentile: Top 9%
Hippo pathway signaling and YAP/TAZ
2.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.